Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice

Accumulation of amyloid β peptides (Aβ) in the brain, which is a hallmark of Alzheimer’s disease (AD), is associated with progressive damage to neuronal processes resulting in extensive neuritic dystrophy. This process may contribute to cognitive decline, but it is not known how Aβ elicits neuritic...

Full description

Bibliographic Details
Main Authors: Alyson L Peel, Dale E Bredesen
Format: Article
Language:English
Published: Elsevier 2003-10-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S096999610300086X
_version_ 1818675810884648960
author Alyson L Peel
Dale E Bredesen
author_facet Alyson L Peel
Dale E Bredesen
author_sort Alyson L Peel
collection DOAJ
description Accumulation of amyloid β peptides (Aβ) in the brain, which is a hallmark of Alzheimer’s disease (AD), is associated with progressive damage to neuronal processes resulting in extensive neuritic dystrophy. This process may contribute to cognitive decline, but it is not known how Aβ elicits neuritic injury. Our analysis of AD brains and related transgenic mouse models suggests an involvement of the interferon-induced serine-threonine protein kinase, PKR, which is best known for its activation upon binding to double-stranded RNA. PKR activation is a component of stress-activated pathways that mobilize somatic cell death programs, but its roles in neurological disease largely remain to be defined. An antibody specific to the activated form of PKR (phosphorylated at T451) was used to determine the pattern of PKR activation in postmortem brain tissues from humans or from transgenic mice that express high levels of familial AD-mutant human amyloid precursor protein (hAPP) and hAPP-derived Aβ in neurons. In contrast to nondemented controls, AD cases showed prominent granular phospho-PKR immunoreactivity in association with neuritic plaques and pyramidal neurons in the hippocampus and neocortex. The distribution of phospho-PKR matched the distributions of abnormally phosphorylated tau and active p38 MAP kinase in adjacent sections. Compared with nontransgenic controls, hAPP transgenic mice also showed strong increases in phospho-PKR in the brain, primarily in association with plaques and dystrophic neurites. These findings support a role for PKR activation in the pathogenesis of AD.
first_indexed 2024-12-17T08:33:30Z
format Article
id doaj.art-b9779c7fd72949caaddf38e8577c2a39
institution Directory Open Access Journal
issn 1095-953X
language English
last_indexed 2024-12-17T08:33:30Z
publishDate 2003-10-01
publisher Elsevier
record_format Article
series Neurobiology of Disease
spelling doaj.art-b9779c7fd72949caaddf38e8577c2a392022-12-21T21:56:32ZengElsevierNeurobiology of Disease1095-953X2003-10-011415262Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic miceAlyson L Peel0Dale E Bredesen1Buck Institute for Age Research, Novato, CA, USABuck Institute for Age Research, Novato, CA, USAAccumulation of amyloid β peptides (Aβ) in the brain, which is a hallmark of Alzheimer’s disease (AD), is associated with progressive damage to neuronal processes resulting in extensive neuritic dystrophy. This process may contribute to cognitive decline, but it is not known how Aβ elicits neuritic injury. Our analysis of AD brains and related transgenic mouse models suggests an involvement of the interferon-induced serine-threonine protein kinase, PKR, which is best known for its activation upon binding to double-stranded RNA. PKR activation is a component of stress-activated pathways that mobilize somatic cell death programs, but its roles in neurological disease largely remain to be defined. An antibody specific to the activated form of PKR (phosphorylated at T451) was used to determine the pattern of PKR activation in postmortem brain tissues from humans or from transgenic mice that express high levels of familial AD-mutant human amyloid precursor protein (hAPP) and hAPP-derived Aβ in neurons. In contrast to nondemented controls, AD cases showed prominent granular phospho-PKR immunoreactivity in association with neuritic plaques and pyramidal neurons in the hippocampus and neocortex. The distribution of phospho-PKR matched the distributions of abnormally phosphorylated tau and active p38 MAP kinase in adjacent sections. Compared with nontransgenic controls, hAPP transgenic mice also showed strong increases in phospho-PKR in the brain, primarily in association with plaques and dystrophic neurites. These findings support a role for PKR activation in the pathogenesis of AD.http://www.sciencedirect.com/science/article/pii/S096999610300086XAlzheimer’s diseasePKRCell stress kinasePlaquesHistopathology
spellingShingle Alyson L Peel
Dale E Bredesen
Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
Neurobiology of Disease
Alzheimer’s disease
PKR
Cell stress kinase
Plaques
Histopathology
title Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
title_full Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
title_fullStr Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
title_full_unstemmed Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
title_short Activation of the cell stress kinase PKR in Alzheimer’s disease and human amyloid precursor protein transgenic mice
title_sort activation of the cell stress kinase pkr in alzheimer s disease and human amyloid precursor protein transgenic mice
topic Alzheimer’s disease
PKR
Cell stress kinase
Plaques
Histopathology
url http://www.sciencedirect.com/science/article/pii/S096999610300086X
work_keys_str_mv AT alysonlpeel activationofthecellstresskinasepkrinalzheimersdiseaseandhumanamyloidprecursorproteintransgenicmice
AT daleebredesen activationofthecellstresskinasepkrinalzheimersdiseaseandhumanamyloidprecursorproteintransgenicmice